http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1638590-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2004-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_467c6064eb25337b15e6447db25a1a5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021284d18349fbcc8ab0180cd119839f |
| publicationDate | 2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1638590-A2 |
| titleOfInvention | Immune enhancing composition containing lactoferrin |
| abstract | The composition of the present invention provides a novel use of the iron binding protein lactoferrin as a medicament to prevent the progression of systemic inflammatory response syndrome (SIRS) into sepsis, severe sepsis, septic shock and multiple organ failure in mammals. More particularly, the present invention is the use of lactoferrin for the manufacture of a medicament for the treatment of the metabolic imbalance in ICU patient. |
| priorityDate | 2003-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.